Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition-Reference-Cited by-同舟云学术

Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition

Published:2009-05 Issue:5 Volume:15 Page:402-415
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Evdokimova Valentina,Tognon Cristina,Ng Tony,Ruzanov Peter,Melnyk Natalya,Fink Dieter,Sorokin Alexey,Ovchinnikov Lev P.,Davicioni Elai,Triche Timothy J.,Sorensen Poul H.B.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference41 articles.

1. Experimental comparison and evaluation of the Affymetrix exon and U133Plus2 GeneChip arrays;Abdueva;PLoS ONE,2007

2. Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation;Bader;Mol. Cell. Biol.,2005

3. Phosphorylation by AKT disables the anti-oncogenic activity of YB-1;Bader;Oncogene,2007

4. The Snail genes as inducers of cell movement and survival: implications in development and cancer;Barrallo-Gimeno;Development,2005

5. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation;Beretta;EMBO J.,1996

Cited by 401 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CircMAN1A2_009 facilitates YBX1 nuclear localization to induce GLO1 activation for cervical adenocarcinoma cell growth;Cancer Science;2024-07-22

2. The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1;Life Sciences;2024-07

3. RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer;Seminars in Cancer Biology;2024-07

4. The Expression of Hsa-Mir-1225-5p Limits the Aggressive Biological Behaviour of Luminal Breast Cancer Cell Lines;MicroRNA;2024-07

5. KMT2D‐mediated H3K4me1 recruits YBX1 to facilitate triple‐negative breast cancer progression through epigenetic activation of c‐Myc;Clinical and Translational Medicine;2024-07